Air Compartment Analysis of nNO and FeNO in RSPH4A-Associated Primary Ciliary Dyskinesia (PCD) vs Asthma

Authors

  • Natalia M. Ortiz Pérez Ponce Health Sciences University, Department of Pediatrics and Basic Sciences Author
  • Gabriel Rosario Ortiz Ponce Health Sciences University, Department of Pediatrics and Basic Sciences Author
  • Frances M. Quiñones Del Toro Ponce Health Sciences University, Department of Pediatrics and Basic Sciences Author
  • Dr. Wilfredo De Jesús Rojas Ponce Health Sciences University, Department of Pediatrics and Basic Sciences Author

DOI:

https://doi.org/10.71332/v4jgyk93

Abstract

PCD is a rare genetic disease that impairs mucociliary clearance and is known to have abnormally low nasal nitric oxide (nNO) levels. In Puerto Rico, a founder variant in RSPH4A [c.921+3_921+6delAAGT] raises the question of whether affected patients show similarly reduced nNO, in contrast to asthma, which usually has normal to elevated nNO and high FeNO from type 2 inflammation. Comparative assessment of NO provides a unique opportunity to differentiate pathophysiological signatures between genetic and inflammatory airway diseases. 

Downloads

Published

2025-12-22